Trial Profile
An open-label, single-dose, 3-period, crossover study to determine the effect of a high-fat meal on the relative bioavailability and pharmacokinetics of a single dose of bazedoxifene acetate/conjugated estrogens (Premarin new process) administered orally to healthy, postmenopausal women
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Conjugated estrogens/bazedoxifene (Primary)
- Indications Atrophic vaginitis; Postmenopausal osteoporosis; Vasomotor symptoms
- Focus Pharmacokinetics
- Sponsors Wyeth
- 07 Jul 2007 New trial record.